{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:23:59Z","timestamp":1778822639783,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1023\/a:1022931403825","type":"journal-article","created":{"date-parts":[[2003,4,7]],"date-time":"2003-04-07T22:16:51Z","timestamp":1049753811000},"page":"149-158","source":"Crossref","is-referenced-by-count":38,"title":["The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer"],"prefix":"10.1007","volume":"78","author":[{"given":"George M.","family":"Yousef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Scorilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terukazu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abd Ellatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Ponzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Biglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furio","family":"Maggiorotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Roagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Sismondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5102491_CR1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(95)92713-1","volume":"346","author":"BS Hulka","year":"1995","unstructured":"Hulka BS, Stark AT: Breast cancer: cause and prevention. Lancet 346: 883-887, 1995","journal-title":"Lancet"},{"key":"5102491_CR2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1023\/A:1008390429428","volume":"11","author":"A Hamilton","year":"2000","unstructured":"Hamilton A, Piccart: The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2. Ann Oncol 11: 647-663, 2000","journal-title":"Ann Oncol"},{"key":"5102491_CR3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","volume":"124","author":"PL Fitzgibbons","year":"2000","unstructured":"Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966-978, 2000","journal-title":"Arch Pathol Lab Med"},{"key":"5102491_CR4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.1998.16.2.793","volume":"16","author":"ASCO","year":"1998","unstructured":"ASCO: 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. J Clin Oncol 16: 793-795, 1998","journal-title":"J Clin Oncol"},{"key":"5102491_CR5","first-page":"22","volume":"30","author":"SJ Schnitt","year":"2001","unstructured":"Schnitt SJ: Traditional and new pathologic factors. J Natl Cancer I 30: 22-26, 2001","journal-title":"J Natl Cancer I"},{"key":"5102491_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","volume":"94","author":"ML Look","year":"2002","unstructured":"Look ML, van Putten WLJ, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Ferno M, Eppenberger-Castori S, Sweep CGJF, Ulm K, Peyrat J-P, Martin P-M, Magdelenat H, Brunner N, Duggan C, Lisboa BW, Bendahl O-P, Quiiillien V, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WF, Blankenstein MA, Broet P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LVAM, Klijn JGM, O'Higgins N, Eppenberger U, Janicke F, Schmitt M, Foekens JA: Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer I 94: 116-128, 2002","journal-title":"J Natl Cancer I"},{"key":"5102491_CR7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.1999.17.3.1080","volume":"17","author":"TJ Smith","year":"1999","unstructured":"Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel 3rd VG, Somerfield MR: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17: 1080-1082, 1999","journal-title":"J Clin Oncol"},{"key":"5102491_CR8","first-page":"4252","volume":"59","author":"GM Yousef","year":"1999","unstructured":"Yousef GM, Obiezu CV, Luo LY, Black MH, Diamandis EP: Prostase\/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res 59: 4252-4256, 1999","journal-title":"Cancer Res"},{"key":"5102491_CR9","doi-asserted-by":"crossref","first-page":"37511","DOI":"10.1074\/jbc.274.53.37511","volume":"274","author":"GM Yousef","year":"1999","unstructured":"Yousef GM, Diamandis EP: The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J Biol Chem 274: 37511-37516, 1999","journal-title":"J Biol Chem"},{"key":"5102491_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/geno.2000.6159","volume":"65","author":"GM Yousef","year":"2000","unstructured":"Yousef GM, Diamandis EP: The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 65: 184-194, 2000","journal-title":"Genomics"},{"key":"5102491_CR11","doi-asserted-by":"crossref","first-page":"11891","DOI":"10.1074\/jbc.275.16.11891","volume":"275","author":"GM Yousef","year":"2000","unstructured":"Yousef GM, Chang A, Diamandis EP: Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J Biol Chem 275: 11891-11898, 2000","journal-title":"J Biol Chem"},{"key":"5102491_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/geno.2000.6346","volume":"69","author":"GM Yousef","year":"2000","unstructured":"Yousef GM, Magklara A, Diamandis EP: KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer. Genomics 69: 331-341, 2000","journal-title":"Genomics"},{"key":"5102491_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1074\/jbc.M005432200","volume":"276","author":"GM Yousef","year":"2001","unstructured":"Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP: Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J Biol Chem 276: 53-61, 2001","journal-title":"J Biol Chem"},{"key":"5102491_CR14","first-page":"3425","volume":"61","author":"GM Yousef","year":"2001","unstructured":"Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP: Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res 61: 3425-3431, 2001","journal-title":"Cancer Res"},{"key":"5102491_CR15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03401646","volume":"2","author":"A Anisowicz","year":"1996","unstructured":"Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R: A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med 2: 624-636, 1996","journal-title":"Mol Med"},{"key":"5102491_CR16","first-page":"3371","volume":"56","author":"XL Liu","year":"1996","unstructured":"Liu XL, Wazer DE, Watanabe K, Band V: Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res 56: 3371-3379, 1996","journal-title":"Cancer Res"},{"key":"5102491_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-1119(98)00232-7","volume":"213","author":"S Yoshida","year":"1998","unstructured":"Yoshida S, Taniguchi M, Hirata A, Shiosaka S: Sequence analysis and expression of human neuropsin cDNA and gene. Gene 213: 9-16, 1998","journal-title":"Gene"},{"key":"5102491_CR18","first-page":"184","volume":"22","author":"GM Yousef","year":"2001","unstructured":"Yousef GM, Diamandis EP: The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 22: 184-204, 2001","journal-title":"Endocr Rev"},{"key":"5102491_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1043-2760(99)00225-8","volume":"11","author":"EP Diamandis","year":"2000","unstructured":"Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV: The new human kallikrein gene family: implications in Carcinogenesis. Trends Endocrin Met 11: 54-60, 2000","journal-title":"Trends Endocrin Met"},{"key":"5102491_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1586\/14737159.1.2.182","volume":"1","author":"EP Diamandis","year":"2001","unstructured":"Diamandis EP, Yousef GM: Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev Mol Diagn 1: 182-190, 2001","journal-title":"Expert Rev Mol Diagn"},{"key":"5102491_CR21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(98)00082-4","volume":"9","author":"EP Diamandis","year":"1998","unstructured":"Diamandis EP: Prostate-specific antigen-its usefulness in clinical medicine. Trends Endocrin Met 9: 310-316, 1998","journal-title":"Trends Endocrin Met"},{"key":"5102491_CR22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/clinchem\/45.6.753","volume":"45","author":"UH Stenman","year":"1999","unstructured":"Stenman, UH: New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease. Clin Chem 45: 753-754, 1999","journal-title":"Clin Chem"},{"key":"5102491_CR23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0090-4295(99)00270-8","volume":"54","author":"AW Partin","year":"1999","unstructured":"Partin, AW, Catalona WJ, Finlay JA, Darte C, Tindall DJ, Young CY, Klee GG, Chan DW, Rittenhouse HG, Wolfert RL, Woodrum DL: Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology 54: 839-845, 1999","journal-title":"Urology"},{"key":"5102491_CR24","first-page":"2104","volume":"55","author":"H Yu","year":"1995","unstructured":"Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJ, Levesque MA, Roagna R, Ponzone R, Sismondi P: Prostatespecific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110, 1995","journal-title":"Cancer Res"},{"key":"5102491_CR25","first-page":"4782","volume":"58","author":"J Goyal","year":"1998","unstructured":"Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V: The role for NES1 serine protease as a novel tumor suppressor. Cancer Res 58: 4782-4786, 1998","journal-title":"Cancer Res"},{"key":"5102491_CR26","first-page":"7811","volume":"61","author":"GM Yousef","year":"2001","unstructured":"Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D: Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res 61: 7811-7818, 2001","journal-title":"Cancer Res"},{"key":"5102491_CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/bjc.1957.43","volume":"11","author":"HJG Bloom","year":"1957","unstructured":"Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957","journal-title":"Br J Cancer"},{"key":"5102491_CR28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0014-2964(80)90064-X","volume":"16","author":"EORTC","year":"1980","unstructured":"EORTC: Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March 1979, in the Netherlands Cancer Institute. Eur J Cancer 16: 1513-1515, 1980","journal-title":"Eur J Cancer"},{"key":"5102491_CR29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR: Regression models and life tables. J R Stat Soc B 34: 187-202, 1972","journal-title":"J R Stat Soc B"},{"key":"5102491_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958","journal-title":"J Am Stat Assoc"},{"key":"5102491_CR31","doi-asserted-by":"crossref","unstructured":"Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP: Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin Chem 2002 (in Press)","DOI":"10.1093\/clinchem\/48.8.1241"},{"key":"5102491_CR32","doi-asserted-by":"crossref","unstructured":"Chang A, Yousef GM, Scorilas A, Grass L, Sismondi P, Ponzone R, Diamandis EP: Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favorable prognosis in breast cancer. Br J Cancer 2002 (in Press)","DOI":"10.1038\/sj.bjc.6600283"},{"key":"5102491_CR33","first-page":"8014","volume":"61","author":"B Li","year":"2001","unstructured":"Li B, Goyal J, Dhar S, Dimri G, Evron E, Sukumar S, Wazer DE, Band V: CpG methylation as a basis for breast tumorspecific loss of NES1\/kallikrein 10 expression. Cancer Res 61: 8014-8021, 2001","journal-title":"Cancer Res"},{"key":"5102491_CR34","first-page":"3393","volume":"7","author":"S Dhar","year":"2001","unstructured":"Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP, Wazer DE, Band V: Analysis of normal epithelial cell specific-1 (NES1)\/Kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res 7: 3393-3398, 2001","journal-title":"Clin Cancer Res"},{"key":"5102491_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1018730519839","volume":"3","author":"SN Birrell","year":"1998","unstructured":"Birrell SN, Hall RE, Tilley WD: Role of the androgen receptor in human breast cancer. J Mammary Gland Biol 3: 95-103, 1998","journal-title":"J Mammary Gland Biol"},{"key":"5102491_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1018770218022","volume":"3","author":"IH Russo","year":"1998","unstructured":"Russo IH, Russo J: Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol 3: 49-61, 1998","journal-title":"J Mammary Gland Biol"},{"key":"5102491_CR37","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jnci\/91.19.1635","volume":"91","author":"AH Fortier","year":"1999","unstructured":"Fortier AH, Nelson BJ, Grella DK, Holaday JW: Antiangiogenic activity of prostate-specific antigen. J Natl Cancer I 91: 1635-1640, 1999","journal-title":"J Natl Cancer I"},{"key":"5102491_CR38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<743::AID-IJC6>3.0.CO;2-#","volume":"66","author":"LC Lai","year":"1996","unstructured":"Lai LC, Erbas H, Lennard TW, Peaston RT: Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer 66: 743-746, 1996","journal-title":"Int J Cancer"},{"key":"5102491_CR39","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/clinchem\/46.7.896","volume":"46","author":"EP Diamandis","year":"2000","unstructured":"Diamandis, EP: Prostate-specific antigen: a cancer fighter and a valuable messenger? Clin Chem 46: 896-900, 2000","journal-title":"Clin Chem"},{"key":"5102491_CR40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00666211","volume":"32","author":"GM Clark","year":"1994","unstructured":"Clark GM, Hilsenbeck SG, Ravdin PM, De Laurentiis M, Osborne CK: Prognostic factors: rationale and methods of analysis and integration. Breast Cancer Res Tr 32: 105-112, 1994","journal-title":"Breast Cancer Res Tr"},{"key":"5102491_CR41","first-page":"4133","volume":"5","author":"M De Laurentiis","year":"1999","unstructured":"De Laurentiis M, De Placido S, Bianco AR, Clark GM, Ravdin PM: A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res 5: 4133-4139, 1999","journal-title":"Clin Cancer Res"},{"key":"5102491_CR42","doi-asserted-by":"crossref","unstructured":"Yousef GM, Diamandis EP: Human kallikreins: common structural features, sequence analysis and evolution. Current Genomics 2002 (in Press)","DOI":"10.2174\/1389202033350074"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1022931403825.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1022931403825\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1022931403825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1022931403825.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:25:51Z","timestamp":1750893951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1022931403825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["5102491"],"URL":"https:\/\/doi.org\/10.1023\/a:1022931403825","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}